HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masoud Soheilian Selected Research

C-Reactive Protein

10/2017C-reactive protein and complement factor H polymorphism interaction in advanced exudative age-related macular degeneration.
9/2017Association of the DNA repair SMUG1 rs3087404 polymorphism and its interaction with high sensitivity C-reactive protein for age-related macular degeneration in Iranian patients.
12/2016Evaluation of C-reactive protein and CC-cytokine ligand 2 polymorphism interaction for age-related macular degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masoud Soheilian Research Topics

Disease

23Macular Edema
04/2023 - 11/2007
21Macular Degeneration (Age-Related Maculopathy)
08/2020 - 06/2007
10Retinal Detachment (Retinal Detachments)
02/2023 - 05/2006
9Uveitis
08/2022 - 07/2008
6Retinal Vein Occlusion
04/2018 - 03/2010
5Diabetic Retinopathy (Retinopathy, Diabetic)
02/2023 - 12/2008
5Inflammation (Inflammations)
12/2017 - 04/2006
5Cataract (Cataracts)
02/2011 - 04/2006
4Proliferative Vitreoretinopathy
02/2023 - 07/2009
3Retinal Perforations
02/2023 - 01/2007
3Behcet Syndrome (Behcet's Syndrome)
01/2022 - 01/2019
3Choroidal Neovascularization
04/2018 - 06/2007
3Ischemia
04/2016 - 05/2011
3Retinitis
01/2016 - 01/2010
3Intraocular Lymphoma
01/2014 - 07/2010
3Vasculitis (Vasculitides)
10/2013 - 01/2010
3Panuveitis
10/2013 - 04/2006
3Foreign Bodies (Foreign Body)
04/2007 - 09/2004
2Epiretinal Membrane (Epiretinal Membranes)
02/2023 - 04/2013
2Disease Progression
04/2020 - 04/2006
2Penetrating Eye Injuries
07/2013 - 04/2007
2Endophthalmitis (Ophthalmia)
07/2013 - 04/2007
2Intermediate Uveitis (Chronic Cyclitis)
01/2013 - 03/2010
2Retinal Vasculitis
10/2011 - 01/2010
2Hemorrhage
10/2011 - 07/2011
2Aneurysm (Aneurysms)
10/2011 - 01/2010
2Ocular Toxoplasmosis
01/2011 - 11/2005
2Cicatrix (Scar)
01/2011 - 12/2005
2Myopia
07/2009 - 12/2007
1Vitamin D Deficiency
11/2022
1Type 2 Diabetes Mellitus (MODY)
11/2022
1Vascular Diseases (Vascular Disease)
04/2018
1Central Serous Chorioretinopathy
04/2018
1Multiple Sclerosis
06/2017
1Lacerations
06/2015
1White Dot Syndromes
11/2013
1Sympathetic Ophthalmia (Sympathetic Uveitis)
06/2012
1Optic Atrophy
10/2011

Drug/Important Bio-Agent (IBA)

21Bevacizumab (Avastin)FDA Link
11/2022 - 06/2007
16Triamcinolone (Aristocort)FDA Link
06/2019 - 06/2007
12Retinaldehyde (Retinal)IBA
04/2020 - 11/2005
9Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
11/2014 - 11/2007
7Adrenal Cortex Hormones (Corticosteroids)IBA
12/2017 - 04/2006
5Complement Factor H (Factor H)IBA
01/2020 - 12/2016
5Prednisolone (Predate)FDA LinkGeneric
06/2017 - 11/2005
5Diclofenac (SR 38)FDA LinkGeneric
06/2015 - 03/2010
5SteroidsIBA
06/2012 - 04/2006
4afliberceptIBA
04/2023 - 03/2017
4Silicone OilsIBA
06/2017 - 05/2006
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2023 - 12/2008
3Adalimumab (Humira)FDA Link
08/2022 - 06/2012
3Complement Factor B (Factor B)IBA
08/2020 - 01/2018
3C-Reactive ProteinIBA
10/2017 - 12/2016
3CytokinesIBA
07/2017 - 12/2016
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
04/2014 - 03/2007
2Complement Factor I (C3b Inactivator)IBA
03/2019 - 01/2018
2Complement C3 (C3 Complement)IBA
07/2017 - 01/2017
2LigandsIBA
12/2016 - 12/2016
2Oxygen (Dioxygen)IBA
04/2016 - 05/2011
2Immunomodulating AgentsIBA
06/2015 - 10/2011
21-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2014 - 06/2007
2Anti-Bacterial Agents (Antibiotics)IBA
07/2013 - 04/2007
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
10/2011 - 01/2010
2Clindamycin (Cleocin)FDA LinkGeneric
01/2011 - 04/2007
2Pyrimethamine (Daraprim)FDA Link
01/2011 - 11/2005
2Methotrexate (Mexate)FDA LinkGeneric
01/2011 - 04/2006
2Sulfadiazine (Sulphadiazine)FDA Link
01/2011 - 11/2005
1Vitamin DFDA LinkGeneric
11/2022
1Biosimilar PharmaceuticalsIBA
08/2022
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2022
1Intravenous Immunoglobulins (IVIG)FDA Link
04/2020
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020
1Complement System Proteins (Complement)IBA
03/2019
1UbiquitinIBA
01/2019
1chemotactic factor inactivatorIBA
01/2018
1DNA (Deoxyribonucleic Acid)IBA
09/2017
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
06/2017
1EnalaprilFDA LinkGeneric
04/2016
1AnthelminticsIBA
01/2016
1SaltsIBA
07/2013
1SolutionsIBA
07/2013
1Betamethasone (Celestone)FDA Link
01/2013
1Immunosuppressive Agents (Immunosuppressants)IBA
06/2012
1ProgesteroneFDA LinkGeneric
07/2011
1Topiramate (Topamax)FDA LinkGeneric
02/2011

Therapy/Procedure

12Vitrectomy
02/2023 - 04/2006
8Intravitreal Injections
04/2018 - 04/2007
8Light Coagulation
02/2018 - 11/2007
8Therapeutics
12/2017 - 11/2005
8Lasers (Laser)
01/2016 - 03/2007
6Injections
04/2023 - 06/2007
3Phacoemulsification
02/2011 - 07/2008
3Intraocular Lens Implantation
02/2011 - 07/2008
3Vitreoretinal Surgery
03/2010 - 05/2005
2Photochemotherapy (Photodynamic Therapy)
10/2014 - 06/2007
2Phakic Intraocular Lenses
06/2012 - 12/2007
2Operative Surgical Procedures
10/2010 - 07/2009
1Intraocular Injections
07/2013
1Cataract Extraction
04/2013